Date | Open | Close | Daily High | Daily Low |
---|
Date | Analyst | Rating | Price |
---|
2025 | 2026 | 2027 | 2028 | 2029 | |
---|---|---|---|---|---|
Revenue | 1,193 | 1,234 | 1,260 | - | - |
Dividend | 0.32 | 0.35 | 0.09 | - | - |
Dividend Yield (in %) | 1.45 % | 1.59 % | 0.41 % | - | - |
EPS | 1.36 | 1.58 | 1.81 | - | - |
P/E Ratio | 16.24 | 13.95 | 12.18 | - | - |
EBIT | 134 | 149 | 143 | - | - |
EBITDA | 239 | 257 | 262 | 258 | 267 |
Net Profit | 64 | 77 | 81 | - | - |
Net Profit Adjusted | 87 | 98 | 94 | - | - |
Pre-Tax Profit | 101 | 118 | 117 | - | - |
Pre-Tax Profit Reported | 70 | 85 | 109 | - | - |
EPS (Non-GAAP) ex. SOE | - | - | - | - | - |
EPS (GAAP) | 1.07 | 1.32 | 1.56 | - | - |
Gross Income | 1,010 | 1,041 | 1,072 | - | - |
Cash Flow from Investing | -85 | -83 | -84 | - | - |
Cash Flow from Operations | 157 | 186 | 201 | - | - |
Cash Flow from Financing | -65 | -26 | -29 | - | - |
Cash Flow per Share | 1.87 | 2.60 | 2.97 | - | - |
Free Cash Flow | 73 | 102 | 117 | 174 | 178 |
Free Cash Flow per Share | 1.74 | 2.15 | 2.54 | - | - |
Book Value per Share | 12.66 | 13.62 | 15.82 | - | - |
Net Debt | 696 | 624 | 530 | 422 | 324 |
Research & Development Exp. | - | - | - | - | - |
Capital Expenditure | 72 | 73 | 68 | - | - |
Selling, General & Admin. Exp. | - | - | - | - | - |
Shareholder’s Equity | 663 | 722 | 838 | - | - |
Total Assets | 1,949 | 2,003 | 2,073 | - | - |
Previous Quarter ending 03/31/25 |
Current Quarter ending 06/30/25 |
Next Quarter ending 09/30/25 |
Current Year ending 12/31/25 |
Next Year ending 12/31/26 |
|
---|---|---|---|---|---|
Earnings Estimates | |||||
No. of Analysts | 1 | - | - | 4 | 4 |
Average Estimate | 0.350 EUR | - | - | 1.358 EUR | 1.580 EUR |
Year Ago | 0.355 EUR | - | - | 0.667 EUR | - |
Publish Date | 4/30/2025 | - | - | - | - |
Revenue Estimates | |||||
No. of Analysts | 2 | - | - | 4 | 4 |
Average Estimate | 286 EUR | - | - | 1,193 EUR | 1,234 EUR |
Year Ago | 285 EUR | - | - | 1,154 EUR | - |
Publish Date | 4/30/2025 | - | - | - | - |
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|---|
Sales | 1,153.99 | 1,187.66 | 1,129.74 | 1,025.32 | 837.26 | 745.81 | 717.02 |
Change of sales in % | -2.84 | 5.13 | 10.18 | 22.46 | 12.26 | 4.01 | 23.07 |
Gross profit on sales | 289.78 | 298.84 | 299.14 | 285.89 | 282.05 | 250.55 | 290.25 |
Gross profit on sales change in % | -3.03 | -0.10 | 4.63 | 1.36 | 12.57 | -13.68 | 43.12 |
Operating income | 89.62 | 155.16 | 126.65 | 123.02 | 136.86 | 108.65 | 132.88 |
Operating income change in % | -42.24 | 22.51 | 2.95 | -10.11 | 25.97 | -18.24 | 66.53 |
Income before tax | 62.69 | 72.05 | 106.92 | 97.84 | 111.36 | 109.53 | 129.04 |
Income before tax change in % | -12.99 | -32.61 | 9.27 | -12.14 | 1.67 | -15.12 | 93.49 |
Income after tax | 34.60 | 45.92 | 73.41 | 68.97 | 73.19 | 65.82 | 92.34 |
Income after tax change in % | -24.65 | -37.45 | 6.44 | -5.77 | 11.20 | -28.72 | 194.91 |
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|---|
Total liabilities | 1,401.22 | 1,319.32 | 1,322.20 | 1,246.93 | 963.61 | 837.43 | 606.73 |
Long-term liabilities per share | 20.68 | 18.65 | 18.12 | 16.22 | 12.53 | 12.42 | 8.78 |
Equity | 648.31 | 669.27 | 673.82 | 612.28 | 638.94 | 259.92 | 273.00 |
Equity change in % | -2.96 | -0.71 | 9.86 | -4.16 | 146.49 | -4.35 | 15.68 |
Balance sheet total | 2,049.53 | 1,988.60 | 1,996.02 | 1,859.21 | 1,602.54 | 1,097.34 | 879.73 |
Balance sheet total change in % | 3.06 | -0.37 | 7.36 | 16.02 | 46.04 | 24.74 | 3.69 |
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|---|
Sales per share | 21.86 | 22.64 | 21.61 | 19.36 | 15.58 | 15.09 | 14.36 |
P/E ratio (year end quote, basic EPS) | 32.62 | 43.12 | 25.60 | 53.98 | 57.71 | 46.89 | 21.55 |
P/E ratio (year end quote, diluted EPS) | 33.20 | 43.30 | 25.63 | 54.65 | 57.71 | 47.87 | 21.87 |
Dividend yield in % | 0.23 | 2.64 | 1.39 | 0.70 | 0.64 | 0.78 | 1.24 |
Equity ratio in % | 31.63 | 33.66 | 33.76 | 32.93 | 39.87 | 23.69 | 31.03 |
Debt ratio in % | 68.37 | 66.34 | 66.24 | 67.07 | 60.13 | 76.31 | 68.97 |
Date | Name | Dividend | *yield | Currency |
---|---|---|---|---|
2024 | CompuGroup Medical SE & Co. KGaA | 0.05 | 0.23 | EUR |
2023 | CompuGroup Medical SE & Co. KGaA | 1.00 | 2.64 | EUR |
2022 | CompuGroup Medical SE & Co. KGaA | 0.50 | 1.39 | EUR |
2021 | CompuGroup Medical SE & Co. KGaA | 0.50 | 0.70 | EUR |
2020 | CompuGroup Medical SE & Co. KGaA | 0.50 | 0.64 | EUR |
2019 | CompuGroup Medical SE & Co. KGaA | 0.50 | 0.78 | EUR |
2018 | CompuGroup Medical SE & Co. KGaA | 0.50 | 1.24 | EUR |
2017 | CompuGroup Medical SE & Co. KGaA | 0.35 | 0.64 | EUR |
2016 | CompuGroup Medical SE & Co. KGaA | 0.35 | 0.90 | EUR |
2015 | CompuGroup Medical SE & Co. KGaA | 0.35 | 1.04 | EUR |
2014 | CompuGroup Medical SE & Co. KGaA | 0.35 | 1.76 | EUR |
2013 | CompuGroup Medical SE & Co. KGaA | 0.35 | 1.89 | EUR |
2012 | CompuGroup Medical SE & Co. KGaA | 0.35 | 2.39 | EUR |
2011 | CompuGroup Medical SE & Co. KGaA | 0.25 | 2.87 | EUR |
2010 | CompuGroup Medical SE & Co. KGaA | 0.25 | 2.26 | EUR |
2009 | CompuGroup Medical SE & Co. KGaA | 0.25 | 3.36 | EUR |
2008 | CompuGroup Medical SE & Co. KGaA | 0.00 | 0.00 | EUR |
2007 | CompuGroup Medical SE & Co. KGaA | 0.00 | 0.00 | EUR |
2006 | CompuGroup Medical SE & Co. KGaA | 0.00 | 0.00 | EUR |
2005 | CompuGroup Medical SE & Co. KGaA | 0.00 | 0.00 | EUR |
2004 | CompuGroup Medical SE & Co. KGaA | 0.00 | 0.00 | EUR |
2003 | CompuGroup Medical SE & Co. KGaA | 0.00 | 0.00 | EUR |
2002 | CompuGroup Medical SE & Co. KGaA | 0.00 | 0.00 | EUR |
2001 | CompuGroup Medical SE & Co. KGaA | 0.00 | 0.00 | EUR |
2000 | CompuGroup Medical SE & Co. KGaA | 0.03 | 2.88 | EUR |
Event | Estimate | Info | Date |
---|---|---|---|
Earnings Report | - | Q2 2025 Earnings Release | 07/31/2025 |
Annual General Meeting | 0.670 EUR | Annual General Meeting | 08/01/2025 |
Earnings Report | - | Q3 2025 Earnings Release | 11/06/2025 |
Earnings Report | - | Q4 2025 Earnings Release | 02/11/2026 |
Earnings Report | - | Q1 2026 Earnings Release | 05/13/2026 |
Earnings Report | - | Q2 2026 Earnings Release | 07/30/2026 |
Event | Actual EPS | Info | Date |
---|---|---|---|
Earnings Report | -0.120 EUR | Q4 2024 Earnings Release | 03/06/2025 |
Earnings Report | 0.170 EUR | Q3 2024 Earnings Release | 11/07/2024 |
Earnings Report | 0.270 EUR | Q2 2024 Earnings Release | 07/15/2024 |
Annual General Meeting | 0.880 EUR | Annual General Meeting | 05/22/2024 |
Earnings Report | 0.350 EUR | Q1 2024 Earnings Release | 05/08/2024 |
Earnings Report | -0.300 EUR | Q4 2023 Earnings Release | 02/07/2024 |
Earnings Report | 0.310 EUR | Q3 2023 Earnings Release | 11/09/2023 |
Earnings Report | 0.600 EUR | Q2 2023 Earnings Release | 08/10/2023 |
Annual General Meeting | 1.410 EUR | Annual General Meeting | 05/17/2023 |
Earnings Report | 0.280 EUR | Q1 2023 Earnings Release | 05/10/2023 |
Earnings Report | 0.260 EUR | Q4 2022 Earnings Release | 02/09/2023 |
Earnings Report | 0.560 EUR | Q3 2022 Earnings Release | 11/03/2022 |
Earnings Report | 0.230 EUR | Q2 2022 Earnings Release | 08/04/2022 |
Annual General Meeting | 1.300 EUR | Annual General Meeting | 05/19/2022 |
Earnings Report | 0.350 EUR | Q1 2022 Earnings Release | 05/05/2022 |
Earnings Report | 0.240 EUR | Q4 2021 Earnings Release | 03/10/2022 |
Name | Job |
---|---|
Philipp von Ilberg | Chairman-Supervisory Board |
Daniel Gotthardt | Chief Executive Officer |
Daniela Hommel | Chief Financial Officer |
Hannes Reichl | Managing Director-Inpatient & Social Care |
Frank Betz | Member-Supervisory Board |
Matthias Wilhelm Störmer | Member-Supervisory Board |
Ayfer Basal | Member-Supervisory Board |
Julia Mole | Member-Supervisory Board |
Martin Köhrmann | Member-Supervisory Board |
Ulrike Handel | Member-Supervisory Board |
Reinhard Lyhs | Member-Supervisory Board |
Adelheid Hegemann | Member-Supervisory Board |
Bettina Volkens | Member-Supervisory Board |
Ali Yener | Member-Supervisory Board |
Claudia Thomé | Senior VP-IR & Head-Corporate Communications |
Stefan Weinmann | Vice Chairman-Supervisory Board |